分组1 - Perrigo reported quarterly earnings of $0.60 per share, exceeding the Zacks Consensus Estimate of $0.56 per share, and showing an increase from $0.29 per share a year ago, representing an earnings surprise of 7.14% [1] - The company posted revenues of $1.04 billion for the quarter ended March 2025, which was 3.59% below the Zacks Consensus Estimate and a decrease from $1.08 billion in the same quarter last year [2] - Over the last four quarters, Perrigo has surpassed consensus EPS estimates three times but has not beaten consensus revenue estimates [2] 分组2 - The current consensus EPS estimate for the upcoming quarter is $0.62 on revenues of $1.08 billion, and for the current fiscal year, it is $2.98 on revenues of $4.42 billion [7] - The Zacks Industry Rank indicates that the Medical - Products sector is currently in the bottom 28% of over 250 Zacks industries, suggesting potential challenges for stock performance [8] - Perrigo shares have declined about 4% since the beginning of the year, slightly outperforming the S&P 500's decline of 4.7% [3]
Perrigo (PRGO) Q1 Earnings Beat Estimates